Life Sciences

life sciences

In the past 25 years Life Science sector has leaded the national economy (with a market share of around 15%), thanks to the high technologies employed and its recognized quality products which have allowed it to succesfully enter extremely strict and controlled markets such as the American, European, and Japanese ones.

See more on Point of View – Nanotechnolgies

See more on Point of View – Biotech

Competitive Advantage

  • 1st Country by number of Advanced Therapy products authorized by the EU (3 out of 5)
  • Worldwide medtech sales are forecast to grow at an annual compound growth rate of 5.1 percent, reaching US$521.9 billion by 2022.